Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension Study.

Kaiser, Peter K; Singer, Michael; Tolentino, Michael; Vitti, Robert; Erickson, Kristine; Saroj, Namrata; Berliner, Alyson J; Chu, Karen W; Zhu, Xiaoping; Williams Liu, Zinaria; Clark, W Lloyd

Kaiser, Peter K; Singer, Michael; Tolentino, Michael; Vitti, Robert; Erickson, Kristine; Saroj, Namrata; Berliner, Alyson J; Chu, Karen W; Zhu, Xiaoping; Williams Liu, Zinaria; Clark, W Lloyd.

Afiliação

Kaiser PK; Cole Eye Institute, Cleveland, Ohio.
Singer M; Medical Center Ophthalmology Associates, San Antonio, Texas.
Tolentino M; Center for Retina and Macular Disease, Winter Haven, Florida.
Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Erickson K; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Saroj N; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Berliner AJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Chu KW; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Zhu X; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Williams Liu Z; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
Clark WL; Palmetto Retina Center, West Columbia, South Carolina. Electronic address: LClark@palmettoretina.com.

Ophthalmol Retina ; 1(4): 304-313, 2017.

Article em En | MEDLINE | ID: mdl-31047516

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ophthalmol Retina Ano de publicação: 2017 Tipo de documento: Article